Rising Cancer Incidence Fuels Growth In Cancer Profiling Market Continues To Impact The Growth Of The Cancer Profiling Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Growth In Market Value Is Anticipated For The Cancer Profiling Market Between 2026 And 2030?

The cancer stem cells market has experienced significant growth in recent years. This market is projected to expand from $3.24 billion in 2025 to $3.59 billion in 2026, showing a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to advancements in stem cell biology research, the identification of cancer stem cell populations, increased funding for oncology research, the expansion of preclinical cancer models, and rising academic-industry collaborations.

The cancer stem cells market size is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $5.31 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this growth during the projection period include the rising need for long-lasting cancer treatments, increased funding for targeted oncology studies, broader implementation of individualized cancer therapy approaches, a heightened emphasis on preventing metastasis, and the greater incorporation of CSC research into clinical oncology practices. Key trends identified for the forecast timeframe encompass an intensified focus on developing treatments for therapy-resistant cancer cells, more extensive investigation into CSC-specific biological pathways, advancing the creation of CSC biomarkers, broader scope in translational and clinical CSC research, and improved utilization of CSC models within drug discovery processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp

Which Strategic Drivers Are Supporting The Cancer Profiling Market Development?

The increasing need for personalized medicine is anticipated to drive expansion in the cancer stem cells market in the foreseeable future. Personalized medicine involves therapeutic strategies crafted specifically for each patient’s genetic profile, tumor characteristics, and individual reactions to treatment, aiming for enhanced efficacy and reduced adverse effects. The growing appetite for personalized medicine is fueled by the accessibility of genomic sequencing technologies, which are progressively more cost-effective and extensively applied in cancer research and patient treatment. By customizing therapies to match the distinct molecular and genetic features of a patient’s tumor, personalized medicine specifically addresses cancer stem cells (CSCs). Initial analysis of tumors identifies mutations, signaling pathways, and surface markers particular to their CSC population, enabling medical professionals to choose treatments that block essential pathways. An example of this trend is that in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that the Food and Drug Administration (FDA) sanctioned 16 novel personalized treatments for patients with rare diseases in 2023, an increase from six in 2022. Therefore, the increasing demand for real-time risk assessment and mitigation solutions is fostering the expansion of the cancer stem cells market.

Which Segment Groups Define The Cancer Profiling Market Landscape?

The cancer profiling market covered in this report is segmented –

1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization

2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers

4) By Application: Research Applications, Clinical Applications, Diagnostics, Prognostics, Other Applications

Subsegments:

1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Luminex xMAP Technology

2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR)

3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq)

4) By Microarrays: DNA Microarrays, RNA Microarrays, SNP Arrays

5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)

What Trends Are Influencing The Cancer Profiling Market?

Companies operating within the cancer stem cells market are increasingly concentrating on technological advancements, such as pre-analytical immunomagnetic sorting systems, to improve cell enrichment for better diagnostic precision. These pre-analytical immunomagnetic sorting systems are sophisticated instruments that utilize magnetic particles coated with antibodies to isolate specific cancer stem cell populations from complex biological samples, thereby enhancing sensitivity and reproducibility in subsequent assays. For instance, in March 2024, STEMCELL Technologies, a Canada-based biotechnology company, introduced the EasySep Human Bone Marrow CD138 Positive Selection Kit. This kit represents the first hematopoietic cell enrichment product to obtain FDA de novo classification as a Class II in vitro diagnostic device. It functions by enriching CD138+ plasma cells from bone marrow samples to enhance the identification of abnormalities linked to multiple myeloma. The product guarantees elevated sensitivity, reproducibility, and diagnostic accuracy, ultimately leading to improved patient outcomes in multiple myeloma care. The fundamental aim of this product is to fortify the pre-analytical phase of cancer diagnostics by providing highly pure cell populations, which facilitates more dependable downstream testing.

Which Companies Are Engaged In The Cancer Profiling Market Environment?

Major companies operating in the cancer profiling market are Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation

Access The Complete Cancer Profiling Market Report:

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Which Region Holds The Largest Share In The Cancer Profiling Market?

North America was the largest region in the cancer profiling market in 2025. The regions covered in the cancer profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cancer Profiling Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9912&type=smp

Browse Through More Reports Similar to the Global Cancer Profiling Market 2026, By The Business Research Company

Hydraulics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydraulics-global-market-report

Smart Elevators Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-elevators-global-market-report

Hydraulic Pumps Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydraulic-pumps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795